OptiNose, Inc. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
OptiNose, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2024.
  • OptiNose, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.05M, a 21.1% decline year-over-year.
  • OptiNose, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$19.2M, a 32.9% increase year-over-year.
  • OptiNose, Inc. annual Operating Income (Loss) for 2023 was -$22.7M, a 59.3% increase from 2022.
  • OptiNose, Inc. annual Operating Income (Loss) for 2022 was -$55.9M, a 15.9% increase from 2021.
  • OptiNose, Inc. annual Operating Income (Loss) for 2021 was -$66.5M, a 23.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$19.2M -$2.05M -$358K -21.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$18.8M -$6.55M -$2.38M -57% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$16.5M -$8.08M +$6.29M +43.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$22.7M -$2.51M +$5.84M +69.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$28.6M -$1.69M +$9.11M +84.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$37.7M -$4.17M +$11.2M +72.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$48.9M -$14.4M +$7.03M +32.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$55.9M -$8.36M +$3.31M +28.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$59.2M -$10.8M +$2.24M +17.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$61.4M -$15.3M +$4.21M +21.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$65.7M -$21.4M +$794K +3.58% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$66.5M -$11.7M +$8.78M +43% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$75.2M -$13M +$4.84M +27.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$80.1M -$19.6M +$3.04M +13.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$83.1M -$22.2M +$4.1M +15.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$87.2M -$20.5M +$2.47M +10.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$89.7M -$17.9M +$1.93M +9.72% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$91.6M -$22.6M +$3.11M +12.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$94.7M -$26.3M +$878K +3.23% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$95.6M -$22.9M +$1.8M +7.27% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$97.4M -$19.8M +$3.68M +15.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$101M -$25.7M -$2.72M -11.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$98.4M -$27.2M +$1.88M +6.48% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$100M -$24.7M -$5.02M -25.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$95.2M -$23.5M -$10.3M -78.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$84.9M -$23M -$14.6M -176% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$70.3M -$29M -$21.7M -298% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$48.5M -$19.7M -$14.8M -303% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-13
Q3 2017 -$33.7M -$13.2M -$7.57M -134% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$26.2M -$8.34M -$3.88M -87% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$22.3M -$7.3M -$47.6M -118% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $25.3M -$4.88M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$5.63M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$4.46M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 $40.3M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.